Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives

Carbon nanotubes (CNTs) have emerged as revolutionary tools, offering innovative approaches to both diagnostic and therapeutic challenges spanning various cancer types. CNTs serve as imaging agents for early detection through MRI, CT, and fluorescence. They provide precise results with biosensors detecting cancer biomarkers for rapid diagnosis. In cancer therapy, CNTs excel in targeted drug delivery, enhancing bioavailability and minimizing off-target effects. Their prowess in photothermal therapy selectively eradicates cancer cells. Despite challenges, ongoing research highlights CNT's transformative potential, promising enhanced precision, efficacy, and personalized cancer care across diverse malignancies in future clinical practice. CNTs show exceptional sensitivity for early cancer diagnosis, detecting biomarkers across cancer types. They enable precise, and personalized treatment by delivering therapeutics directly to cancer cells, minimizing toxicity. CNTs enhance imaging modalities and are combined with AI for improved diagnosis and treatment planning, showing transformative potential in multiple cancers. image